BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piketty M, Prie D, Sedel F, Bernard D, Hercend C, Chanson P, Souberbielle J. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference. Clinical Chemistry and Laboratory Medicine (CCLM) 2017;55:817-25. [DOI: 10.1515/cclm-2016-1183] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Meng QH. Evolving hyperthyroidism? Clinical Biochemistry 2020;75:83-4. [DOI: 10.1016/j.clinbiochem.2019.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Harley K, Bissonnette S, Inzitari R, Schulz K, Apple FS, Kavsak PA, Gunsolus IL. Independent and combined effects of biotin and hemolysis on high-sensitivity cardiac troponin assays. Clin Chem Lab Med 2021;59:1431-43. [PMID: 33761581 DOI: 10.1515/cclm-2021-0124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mock DM. Biotin: From Nutrition to Therapeutics. J Nutr 2017;147:1487-92. [PMID: 28701385 DOI: 10.3945/jn.116.238956] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]
4 Li D, Ferguson A, Cervinski MA, Lynch KL, Kyle PB. AACC Guidance Document on Biotin Interference in Laboratory Tests. J Appl Lab Med 2020;5:575-87. [PMID: 32445355 DOI: 10.1093/jalm/jfz010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
5 Pourcher V, Todesco E, Dubois C, Pallier C, Lubetzki C, Louapre C, Papeix C, Maillart E. False hepatitis B and C viral serologies in patients with multiple sclerosis receiving high-dose biotin. Mult Scler 2020;26:257-8. [DOI: 10.1177/1352458518818294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Lefèvre CR, Peltier L, Damaj L, Valaize J, Bendavid C, Moreau C. Immunoassay Disruption by High-Dose Biotin Therapy: Fair Warning for Neonatal Care Physicians. Pediatric Neurology 2020;112:8-9. [DOI: 10.1016/j.pediatrneurol.2020.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Avery G. Biotin interference in immunoassay: a review for the laboratory scientist. Ann Clin Biochem 2019;56:424-30. [DOI: 10.1177/0004563219842231] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
8 Carter GD, Berry J, Cavalier E, Durazo-Arvizu R, Gunter E, Jones G, Jones J, Phinney K, Sempos CT, Twomey PJ, Williams EL. Biotin supplementation causes erroneous elevations of results in some commercial serum 25-hydroxyvitamin d (25OHD) assays. J Steroid Biochem Mol Biol 2020;200:105639. [PMID: 32084550 DOI: 10.1016/j.jsbmb.2020.105639] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Favresse J, Bayart J, Stoefs A, Gheldof D, Douxfils J, Dogné J, Gruson D. Neutralization of biotin interference: preliminary evaluation of the VeraTest Biotin™, VeraPrep Biotin™ and BioT-Filter ®. Clinical Chemistry and Laboratory Medicine (CCLM) 2020;58:e130-3. [DOI: 10.1515/cclm-2019-1121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Buzid A, McGlacken GP, Glennon JD, Luong JHT. Electrochemical Sensing of Biotin Using Nafion-Modified Boron-Doped Diamond Electrode. ACS Omega 2018;3:7776-82. [PMID: 30087922 DOI: 10.1021/acsomega.8b01209] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Nelson HA, La'ulu SL, Lu J, Doyle K. Mitigation of Biotin Interference in Manual and Automated Immunoassays by Preconjugating Biotinylated Antibodies to the Streptavidin Surface as an Alternative to Biotin Depletion. J Appl Lab Med 2022:jfab169. [PMID: 35018420 DOI: 10.1093/jalm/jfab169] [Reference Citation Analysis]
12 Bouillet B, Rouland A. [Intake of high dose biotin: A cause of artificial hyperthyroidism]. Rev Med Interne 2020;41:123-5. [PMID: 31813616 DOI: 10.1016/j.revmed.2019.11.005] [Reference Citation Analysis]
13 Vashist SK, Luong JH. Bioanalytical Requirements and Regulatory Guidelines for Immunoassays. Handbook of Immunoassay Technologies. Elsevier; 2018. pp. 81-95. [DOI: 10.1016/b978-0-12-811762-0.00004-9] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
14 Lackner KJ. Cardiac biomarkers – 2019. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;57:565-6. [DOI: 10.1515/cclm-2019-0205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Ranaivosoa MK, Ganel S, Agin A, Romain S, Parent X, Reix N. Insuffisance rénale chronique et biotine : un duo propice aux bilans thyroïdiens et parathyroïdiens erronés, à propos de 2 cas. Néphrologie & Thérapeutique 2017;13:553-8. [DOI: 10.1016/j.nephro.2017.02.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
16 Lam L, Bagg W, Smith G, Chiu WW, Middleditch MJ, Lim JC, Kyle CV. Apparent Hyperthyroidism Caused by Biotin-Like Interference from IgM Anti-Streptavidin Antibodies. Thyroid 2018;28:1063-7. [DOI: 10.1089/thy.2017.0673] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
17 Ardabilygazir A, Afshariyamchlou S, Mir D, Sachmechi I. Effect of High-dose Biotin on Thyroid Function Tests: Case Report and Literature Review. Cureus 2018;10:e2845. [PMID: 30140596 DOI: 10.7759/cureus.2845] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
18 Soh SB, Aw TC. Laboratory Testing in Thyroid Conditions - Pitfalls and Clinical Utility. Ann Lab Med 2019;39:3-14. [PMID: 30215224 DOI: 10.3343/alm.2019.39.1.3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
19 Katzman BM, Lueke AJ, Donato LJ, Jaffe AS, Baumann NA. Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department. Clin Biochem 2018;60:11-6. [PMID: 30036510 DOI: 10.1016/j.clinbiochem.2018.07.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
20 Silva BC, Cusano NE, Bilezikian JP. Primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 2018;:101247. [PMID: 30477754 DOI: 10.1016/j.beem.2018.09.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
21 Ricci V, Esteban MP, Sand G, Menises MM. Interference of anti-streptavidin antibodies: More common than we thought? In relation to six confirmed cases. Clin Biochem 2021;90:62-5. [PMID: 33545112 DOI: 10.1016/j.clinbiochem.2021.01.013] [Reference Citation Analysis]
22 Koehler VF, Mann U, Nassour A, Mann W. Fake news? Biotin interference in thyroid immunoassays. Clinica Chimica Acta 2018;484:320-2. [DOI: 10.1016/j.cca.2018.05.053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
23 Li D, Radulescu A, Shrestha RT, Root M, Karger AB, Killeen AA, Hodges JS, Fan SL, Ferguson A, Garg U, Sokoll LJ, Burmeister LA. Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults. JAMA 2017;318:1150-60. [PMID: 28973622 DOI: 10.1001/jama.2017.13705] [Cited by in Crossref: 73] [Cited by in F6Publishing: 51] [Article Influence: 14.6] [Reference Citation Analysis]
24 Schrapp A, Fraissinet F, Hervouet C, Girot H, Brunel V. Biotin and high-sensitivity cardiac troponin T assay. Biochem Med (Zagreb) 2018;28:030901. [PMID: 30429682 DOI: 10.11613/BM.2018.030901] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
25 Katzman BM, Hain EA, Donato LJ, Baumann NA. Validation of a Commercial Reagent for the Depletion of Biotin from Serum/Plasma: A Rapid and Simple Tool to Detect Biotin Interference with Immunoassay Testing. J Appl Lab Med 2021;6:992-7. [PMID: 33907809 DOI: 10.1093/jalm/jfab022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Trambas C. Biotin interference in clinical laboratory tests. Accurate Results in the Clinical Laboratory. Elsevier; 2019. pp. 83-97. [DOI: 10.1016/b978-0-12-813776-5.00008-x] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Favresse J, Stoefs A, Bayart JL, Burlacu MC, Maisin D, Maiter D, Gruson D. A Challenging Case of Falsely Elevated Free Thyroid Hormones. J Appl Lab Med 2020;5:406-11. [PMID: 32445369 DOI: 10.1093/jalm/jfz027] [Reference Citation Analysis]
28 von Meyer A, Albert G, Kunzelmann S, Rank C, Zerback R, Imdahl R. Evaluating the performance of an updated high-sensitivity troponin T assay with increased tolerance to biotin. Clin Chem Lab Med 2021;59:591-7. [PMID: 33112775 DOI: 10.1515/cclm-2020-0104] [Reference Citation Analysis]
29 Favresse J, Gruson D, Gheldof D. Comment on "High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders". Mol Genet Metab Rep 2019;21:100506. [PMID: 31467852 DOI: 10.1016/j.ymgmr.2019.100506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
30 Li J, Wagar EA, Meng QH. Comprehensive assessment of biotin interference in immunoassays. Clinica Chimica Acta 2018;487:293-8. [DOI: 10.1016/j.cca.2018.10.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
31 Frame IJ, Joshi PH, Mwangi C, Gunsolus I, De Lemos JA, Das SR, Sarode R, Balani J, Apple FS, Muthukumar A. Susceptibility of Cardiac Troponin Assays to Biotin Interference. American Journal of Clinical Pathology 2019;151:486-93. [DOI: 10.1093/ajcp/aqy172] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
32 Ruth I, Mathieu E, Burniat A, Fage D, Cotton F, Wolff F. Interferences in free thyroxine concentration using the Roche analytical platform: improvement of the third generation? Clin Chem Lab Med 2020;58:e36-9. [PMID: 31377735 DOI: 10.1515/cclm-2019-0525] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
33 Yang J, Wiencek JR. Mitigating biotin interference in two Roche immunoassays by premixing biotinylated capturing molecules with streptavidin coated beads. Clin Chim Acta 2020;505:130-5. [PMID: 32084383 DOI: 10.1016/j.cca.2020.02.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
34 Samarasinghe S, Meah F, Singh V, Basit A, Emanuele N, Emanuele MA, Mazhari A, Holmes EW. BIOTIN INTERFERENCE WITH ROUTINE CLINICAL IMMUNOASSAYS: UNDERSTAND THE CAUSES AND MITIGATE THE RISKS. Endocr Pract 2017;23:989-98. [PMID: 28534685 DOI: 10.4158/EP171761.RA] [Cited by in Crossref: 60] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
35 Öncül Ü, Eminoğlu FT, Köse E, Doğan Ö, Özsu E, Aycan Z. Serum biotin interference: A troublemaker in hormone immunoassays. Clin Biochem 2022;99:97-102. [PMID: 34736903 DOI: 10.1016/j.clinbiochem.2021.10.011] [Reference Citation Analysis]
36 Wauthier L, Plebani M, Favresse J. Interferences in immunoassays: review and practical algorithm. Clin Chem Lab Med 2022. [PMID: 35304841 DOI: 10.1515/cclm-2021-1288] [Reference Citation Analysis]
37 Odhaib SA, Mansour AA, Haddad NS. How Biotin Induces Misleading Results in Thyroid Bioassays: Case Series. Cureus 2019;11:e4727. [PMID: 31363424 DOI: 10.7759/cureus.4727] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
38 Honour JW. Biochemistry of the menopause. Ann Clin Biochem 2018;55:18-33. [PMID: 29027807 DOI: 10.1177/0004563217739930] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
39 Gunsolus IL, Matias M, Prostko J, Mohr P, Sokoll LJ. Prevalence of Detectable Biotin in Five US Emergency Department Patient Cohorts. Clin Biochem 2021;93:26-32. [PMID: 33771568 DOI: 10.1016/j.clinbiochem.2021.03.009] [Reference Citation Analysis]
40 Favresse J, Burlacu M, Maiter D, Gruson D. Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm. Endocrine Reviews 2018;39:830-50. [DOI: 10.1210/er.2018-00119] [Reference Citation Analysis]
41 Raverot V, Bordeau É, Periot C, Perrin P, Chardon L, Plotton I, Nouvel M, Lapoirie M, Borson-chazot F. Letter to the editor: A case of laboratory-generated “thyroid dysfunction”. Annales d'Endocrinologie 2019;80:140-1. [DOI: 10.1016/j.ando.2018.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Dasgupta A, Bourgeois L. Biotin interference in TSH, FT4, and FT3 assays based on the LOCI technology: Identifying interference by dilution. J Clin Lab Anal 2019;33:e22667. [PMID: 30221397 DOI: 10.1002/jcla.22667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
43 Saenger AK, Jaffe AS, Body R, Collinson PO, Kavsak PA, Lam CS, Lefèvre G, Omland T, Ordóñez-llanos J, Pulkki K, Apple FS. Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB). Clinical Chemistry and Laboratory Medicine (CCLM) 2019;57:633-40. [DOI: 10.1515/cclm-2018-0905] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
44 Moerman A, R. Delanghe J. Sense and nonsense concerning biotin interference in laboratory tests. Acta Clinica Belgica. [DOI: 10.1080/17843286.2020.1780770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Walker MD, Bilezikian JP. Primary hyperparathyroidism: recent advances. Current Opinion in Rheumatology 2018;30:427-39. [DOI: 10.1097/bor.0000000000000511] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
46 Wolf B. High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders. Molecular Genetics and Metabolism 2019;127:321-4. [DOI: 10.1016/j.ymgme.2019.07.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
47 Ghazal K, Piketty ML. Comment on biotin-induced thyroid stimulating hormone aberrations in the setting of immunotherapy. J Oncol Pharm Pract 2021;27:1562-3. [PMID: 34233545 DOI: 10.1177/10781552211029706] [Reference Citation Analysis]
48 Yang J, Wiencek JR. Biotin sulfoxide is an interferent in several Roche cobas e411 immunoassays. Clin Chim Acta 2020;510:12-4. [PMID: 32628921 DOI: 10.1016/j.cca.2020.06.050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Tsai K, Leung AM. Subclinical Hyperthyroidism: A Review of the Clinical Literature. Endocrine Practice 2021;27:254-60. [DOI: 10.1016/j.eprac.2021.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Garg U. Biotin Interference in Certain Immunoassays: Risk of Misdiagnosis and Mismanagement. J Appl Lab Med 2020;5:436-9. [PMID: 32445349 DOI: 10.1093/jalm/jfaa040] [Reference Citation Analysis]
51 Ghazal K, Brabant S, Prie D, Piketty ML. Hormone Immunoassay Interference: A 2021 Update. Ann Lab Med 2022;42:3-23. [PMID: 34374345 DOI: 10.3343/alm.2022.42.1.3] [Reference Citation Analysis]
52 Bowen R, Benavides R, Colón-franco JM, Katzman BM, Muthukumar A, Sadrzadeh H, Straseski J, Klause U, Tran N. Best practices in mitigating the risk of biotin interference with laboratory testing. Clinical Biochemistry 2019;74:1-11. [DOI: 10.1016/j.clinbiochem.2019.08.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
53 Bayart JL, Favresse J, Stoefs A, Closset M, Roy T, Fillée C, Rodriguez-Villalobos H, Kabamba-Mukadi B, Gruson D. Biotin interferences: Have we neglected the impact on serological markers? Clin Chim Acta 2020;503:107-12. [PMID: 31978405 DOI: 10.1016/j.cca.2020.01.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
54 Buzid A, Hayes PE, Glennon JD, Luong JH. Captavidin as a regenerable biorecognition element on boron-doped diamond for biotin sensing. Analytica Chimica Acta 2019;1059:42-8. [DOI: 10.1016/j.aca.2019.01.058] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
55 Pugeat M, Plotton I, de la Perrière AB, Raverot G, Déchaud H, Raverot V. MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis. European Journal of Endocrinology 2018;178:R141-54. [DOI: 10.1530/eje-17-0776] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 2.8] [Reference Citation Analysis]
56 Silva BC, Cusano NE, Bilezikian JP. Primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32:593-607. [PMID: 30449543 DOI: 10.1016/j.beem.2018.09.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 8.8] [Reference Citation Analysis]
57 Binart N, Young J, Chanson P. Prolactin Assays and Regulation of Secretion: Animal and Human Data. In: Tritos NA, Klibanski A, editors. Prolactin Disorders. Cham: Springer International Publishing; 2019. pp. 55-78. [DOI: 10.1007/978-3-030-11836-5_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
58 Dahll LK, Haave EM, Dahl SR, Aas FE, Thorsby PM. Endogenous anti-streptavidin antibodies causing erroneous laboratory results more common than anticipated. Scandinavian Journal of Clinical and Laboratory Investigation 2021;81:92-103. [DOI: 10.1080/00365513.2020.1858493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Haslam S, Oakey J, Brown A, Bradshaw S, Myers M. A comparison of biotin interference in routine immunoassays on the Roche Cobas 8000, Beckman Coulter DXi and Siemens Advia Centaur XPT immunoassay platforms. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;57:e287-90. [DOI: 10.1515/cclm-2019-0078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
60 Goichot B, Leenhardt L, Massart C, Raverot V, Tramalloni J, Iraqi H; Consensus work-group. Diagnostic procedure in suspected Graves' disease. Ann Endocrinol (Paris) 2018;79:608-17. [PMID: 30220410 DOI: 10.1016/j.ando.2018.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
61 Mumma B, Diercks D, Twerenbold R, Valcour A, Ziegler A, Schützenmeister A, Kasapic D, Tran N. Clinical risk assessment of biotin interference with a high-sensitivity cardiac troponin T assay. Clinical Chemistry and Laboratory Medicine (CCLM) 2020;58:1931-40. [DOI: 10.1515/cclm-2019-0962] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
62 Couloume L, Barbin L, Leray E, Wiertlewski S, Le Page E, Kerbrat A, Ory S, Le Port D, Edan G, Laplaud D, Michel L. High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice. Mult Scler 2020;26:1898-906. [DOI: 10.1177/1352458519894713] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
63 Johnson L, Li D. Strategies to Investigate Biotin Interference in Light of the FDA Safety Communication. The Journal of Applied Laboratory Medicine 2019;3:914-5. [DOI: 10.1373/jalm.2018.026294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
64 Ijpelaar A, Beijers A, van Daal H, van den Ouweland J. Prevalence of detectable biotin in The Netherlands in relation to risk on immunoassay interference. Clinical Biochemistry 2020;83:78-80. [DOI: 10.1016/j.clinbiochem.2020.05.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
65 Mzougui S, Favresse J, Soleimani R, Fillée C, Gruson D. Biotin interference: evaluation of a new generation of electrochemiluminescent immunoassays for high-sensitive troponin T and thyroid-stimulating hormone testing. Clinical Chemistry and Laboratory Medicine (CCLM) 2020;58:2037-45. [DOI: 10.1515/cclm-2020-0214] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
66 Favresse J, Bayart JL, Burlacu MC, Maiter D, Dogné JM, Douxfils J, Gruson D. Usefulness of a Non-Streptavidin Bead Technology to Overcome Biotin Interference: Proof of Principle with 25-OH Vitamin D, TSH, and FT4. J Appl Lab Med 2021;6:1072-7. [PMID: 33382887 DOI: 10.1093/jalm/jfaa203] [Reference Citation Analysis]
67 Berth M, Willaert S, De Ridder C. Anti-streptavidin IgG antibody interference in anti-cyclic citrullinated peptide (CCP) IgG antibody assays is a rare but important cause of false-positive anti-CCP results. Clinical Chemistry and Laboratory Medicine (CCLM) 2018;56:1263-8. [DOI: 10.1515/cclm-2017-1153] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
68 Clerico A, Zaninotto M, Passino C, Padoan A, Migliardi M, Plebani M. High-sensitivity methods for cardiac troponins: The mission is not over yet. Adv Clin Chem 2021;103:215-52. [PMID: 34229851 DOI: 10.1016/bs.acc.2020.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Favresse J, Burlacu M, Maiter D, Gruson D. Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm. Endocrine Reviews 2018;39:830-50. [DOI: 10.1210/er.2018-00119] [Cited by in Crossref: 73] [Cited by in F6Publishing: 55] [Article Influence: 18.3] [Reference Citation Analysis]
70 Evenepoel A, Schiettecatte J, Van Dalem A, Anckaert E. Biotin interference: evaluation of an updated thyroglobulin electrochemiluminescent immunoassay. Clin Chem Lab Med 2021. [PMID: 34662931 DOI: 10.1515/cclm-2021-0969] [Reference Citation Analysis]
71 Clerico A, Plebani M. Biotin interference on immunoassay methods: sporadic cases or hidden epidemic? Clinical Chemistry and Laboratory Medicine (CCLM) 2017;55:777-9. [DOI: 10.1515/cclm-2017-0070] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
72 Verougstraete N, Berth M, Vaneechoutte M, Delanghe J, Callewaert N. Interference of anti-streptavidin antibodies in immunoassays: a very rare phenomenon or a more common finding? Clinical Chemistry and Laboratory Medicine (CCLM) 2020;58:1673-80. [DOI: 10.1515/cclm-2019-1064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
73 Bilezikian JP. Primary Hyperparathyroidism. J Clin Endocrinol Metab 2018;103:3993-4004. [PMID: 30060226 DOI: 10.1210/jc.2018-01225] [Cited by in Crossref: 85] [Cited by in F6Publishing: 54] [Article Influence: 28.3] [Reference Citation Analysis]
74 Bayart J, Favresse J, Melnik E, Lardinois B, Fillée C, Maiter D, Gruson PD. Erroneous thyroid and steroid hormones profile due to anti-streptavidin antibodies. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;57:e255-8. [DOI: 10.1515/cclm-2018-1355] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
75 Wouters Y, Oosterbos J, Reynaert N, Penders J. Alarmed by misleading interference in free T3 and free T4 assays: a new case of anti-streptavidin antibodies. Clin Chem Lab Med 2020;58:e69-71. [PMID: 31605576 DOI: 10.1515/cclm-2019-0845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Al-Salameh A, Becquemont L, Brailly-Tabard S, Aubourg P, Chanson P. A Somewhat Bizarre Case of Graves Disease Due to Vitamin Treatment. J Endocr Soc 2017;1:431-5. [PMID: 29264498 DOI: 10.1210/js.2017-00054] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]